InsiderTrades.com logo
A One Stop Shop for Everything Futures Trading
From RJO Futures   |   Ad
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

GTHX Insider Trading (G1 Therapeutics)

Insider Ownership Percentage: 8.09%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $373,922.86

G1 Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at G1 Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

G1 Therapeutics Share Price & Price History

Current Price: $12.87
Price Change: ▲ Price Increase of +0.8 (6.63%)
As of 08/12/2022 01:00 AM ET

This chart shows the closing price history over time for GTHX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
A One Stop Shop for Everything Futures Trading
From RJO Futures   |   Ad
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

G1 Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/5/2022Terry L MurdockCOOSell648$5.17$3,350.1620,907View SEC Filing Icon  
1/5/2022James Stillman HansonGeneral CounselSell1,445$10.61$15,331.45View SEC Filing Icon  
1/3/2022John E (Jack) Bailey, Jr.CEOSell34,125$10.41$355,241.25View SEC Filing Icon  
7/15/2021Mark A. VellecaDirectorSell10,000$18.49$184,900.0071,000View SEC Filing Icon  
7/13/2021Mark A. VellecaDirectorSell10,000$19.45$194,500.0071,000View SEC Filing Icon  
6/17/2021Mark A. VellecaDirectorSell10,000$21.77$217,700.0071,000View SEC Filing Icon  
6/15/2021Mark A. VellecaDirectorSell10,000$22.39$223,900.0071,000View SEC Filing Icon  
5/13/2021Mark A. VellecaDirectorSell30,000$19.90$597,000.00
5/11/2021Mark A. VellecaDirectorSell10,000$19.10$191,000.0051,000View SEC Filing Icon  
4/22/2021Rajesh MalikInsiderSell15,000$22.07$331,050.00View SEC Filing Icon  
4/14/2021Mark A. VellecaDirectorSell10,000$24.53$245,300.0051,000View SEC Filing Icon  
3/23/2021Rajesh MalikInsiderSell15,000$21.94$329,100.00View SEC Filing Icon  
2/18/2021Mark A. VellecaDirectorSell10,000$26.02$260,200.0052,040View SEC Filing Icon  
2/16/2021Mark A. VellecaDirectorSell11,040$35.20$388,608.0052,040View SEC Filing Icon  
1/22/2021Rajesh MalikInsiderSell15,000$20.64$309,600.00View SEC Filing Icon  
1/20/2021Mark A. VellecaDirectorSell10,000$21.51$215,100.0047,000View SEC Filing Icon  
12/24/2020Seth RudnickDirectorSell924$20.10$18,572.40View SEC Filing Icon  
12/22/2020Seth RudnickDirectorSell18,974$20.33$385,741.42View SEC Filing Icon  
12/17/2020Mark A. VellecaCEOSell30,000$19.53$585,900.0047,000View SEC Filing Icon  
12/15/2020Mark A. VellecaCEOSell10,000$19.43$194,300.0047,000View SEC Filing Icon  
12/10/2020Rajesh MalikSVPSell9,000$20.06$180,540.0038,200View SEC Filing Icon  
12/10/2020Seth RudnickDirectorSell546$20.00$10,920.00View SEC Filing Icon  
12/8/2020Seth RudnickDirectorSell13,161$20.19$265,720.59View SEC Filing Icon  
12/1/2020Seth RudnickDirectorSell520$20.09$10,446.80View SEC Filing Icon  
11/18/2020Glenn P MuirDirectorBuy50,000$13.50$675,000.00170,969View SEC Filing Icon  
9/4/2020James Stillman HansonGeneral CounselBuy1,000$14.95$14,950.004,000View SEC Filing Icon  
See Full Table
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

SEC Filings (Institutional Ownership Changes) for G1 Therapeutics (NASDAQ:GTHX)

61.89% of G1 Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at GTHX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

G1 Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/13/2022Quantbot Technologies LP26,287$0.13M0.0%N/A0.061%Search for SEC Filing on Google Icon
8/13/2022Virtu Financial LLC10,081$50K0.0%N/A0.024%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC464,000$2.29M0.0%N/A1.085%Search for SEC Filing on Google Icon
8/13/2022Needham Investment Management LLC134,000$0.66M0.1%-16.3%0.313%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp91,891$0.45M0.0%-76.5%0.215%Search for SEC Filing on Google Icon
8/12/2022Ensign Peak Advisors Inc25,220$0.13M0.0%+225.8%0.059%Search for SEC Filing on Google Icon
8/12/2022FMR LLC488,707$2.41M0.0%+0.2%1.143%Search for SEC Filing on Google Icon
8/11/2022Trexquant Investment LP18,171$90K0.0%N/A0.043%Search for SEC Filing on Google Icon
8/11/2022JPMorgan Chase & Co.2,129,449$10.52M0.0%+1.5%4.981%Search for SEC Filing on Google Icon
8/8/2022Bay Colony Advisory Group Inc d b a Bay Colony Advisors14,195$0.12M0.0%N/A0.033%Search for SEC Filing on Google Icon
8/8/2022Curi Wealth Management LLC84,737$0.42M0.1%N/A0.198%Search for SEC Filing on Google Icon
8/8/2022Y Intercept Hong Kong Ltd17,100$84K0.0%N/A0.040%Search for SEC Filing on Google Icon
8/5/2022Connor Clark & Lunn Investment Management Ltd.39,658$0.20M0.0%N/A0.093%Search for SEC Filing on Google Icon
8/3/2022Envestnet Asset Management Inc.10,772$53K0.0%N/A0.025%Search for SEC Filing on Google Icon
6/30/2022Amalgamated Bank5,782$44K0.0%N/A0.014%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE362,573$2.76M0.0%-2.7%0.849%Search for SEC Filing on Google Icon
5/18/2022BNP Paribas Arbitrage SA3,490$27K0.0%-91.1%0.008%Search for SEC Filing on Google Icon
5/17/2022Beacon Pointe Advisors LLC11,500$87K0.0%N/A0.027%Search for SEC Filing on Google Icon
5/17/2022Point72 Hong Kong Ltd10,858$83K0.0%N/A0.025%Search for SEC Filing on Google Icon
5/17/2022Dynamic Technology Lab Private Ltd24,187$0.18M0.0%N/A0.057%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System42,532$0.32M0.0%-8.0%0.100%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.445,137$3.38M0.0%+15.9%1.042%Search for SEC Filing on Google Icon
5/16/2022Pinz Capital Management LP186,515$1.42M0.9%N/A0.437%Search for SEC Filing on Google Icon
5/16/2022Wellington Management Group LLP82,214$0.62M0.0%-11.7%0.193%Search for SEC Filing on Google Icon
5/16/2022State Street Corp3,676,814$27.94M0.0%-14.5%8.610%Search for SEC Filing on Google Icon
5/16/2022Graham Capital Management L.P.15,741$0.12M0.0%N/A0.037%Search for SEC Filing on Google Icon
5/16/2022Invesco Ltd.16,108$0.12M0.0%-34.7%0.038%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG222,919$1.69M0.0%-13.5%0.522%Search for SEC Filing on Google Icon
5/13/2022Rhenman & Partners Asset Management AB316,137$2.40M0.2%-2.7%0.740%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp390,586$2.97M0.0%-4.0%0.915%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.266,345$2.03M0.0%+2.2%0.624%Search for SEC Filing on Google Icon
5/13/2022Federated Hermes Inc.39,600$0.30M0.0%+49.3%0.093%Search for SEC Filing on Google Icon
5/13/2022Ergoteles LLC36,200$0.28M0.0%+10.5%0.085%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.1,923,704$14.62M0.0%-24.4%4.504%Search for SEC Filing on Google Icon
5/13/2022Dimensional Fund Advisors LP566,011$4.30M0.0%+7.9%1.325%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.3,299,849$25.08M0.0%-0.3%7.727%Search for SEC Filing on Google Icon
5/12/2022MetLife Investment Management LLC23,409$0.18M0.0%+56.5%0.055%Search for SEC Filing on Google Icon
5/12/2022Citigroup Inc.42,054$0.32M0.0%-84.3%0.098%Search for SEC Filing on Google Icon
5/11/2022Raymond James Financial Services Advisors Inc.53,625$0.41M0.0%+6.7%0.126%Search for SEC Filing on Google Icon
5/11/2022Raymond James & Associates397,879$3.02M0.0%+72.0%0.932%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.2,097,753$15.94M0.0%-2.1%4.912%Search for SEC Filing on Google Icon
5/10/2022ProShare Advisors LLC11,849$90K0.0%-19.1%0.028%Search for SEC Filing on Google Icon
5/9/2022Swiss National Bank70,400$0.54M0.0%+9.1%0.165%Search for SEC Filing on Google Icon
5/9/2022Qube Research & Technologies Ltd16,622$0.13M0.0%-47.1%0.039%Search for SEC Filing on Google Icon
5/5/2022Fisher Asset Management LLC2,311,138$17.57M0.0%+1.9%5.411%Search for SEC Filing on Google Icon
4/29/2022SG Americas Securities LLC38,014$0.29M0.0%-18.5%0.089%Search for SEC Filing on Google Icon
4/18/2022Golden Green Inc.12,152$92K0.1%-70.7%0.028%Search for SEC Filing on Google Icon
4/11/2022Nordea Investment Management AB397,746$3.13M0.0%+1.4%0.931%Search for SEC Filing on Google Icon
2/14/2022Lombard Odier Asset Management Switzerland SA1,049,947$10.72M0.7%+9.2%2.469%Search for SEC Filing on Google Icon
2/14/2022Virtus ETF Advisers LLC16,088$0.16M0.1%+72.2%0.038%Search for SEC Filing on Google Icon
2/14/2022Needham Investment Management LLC115,000$1.17M0.1%+29.9%0.270%Search for SEC Filing on Google Icon
2/11/2022Ensign Peak Advisors Inc7,740$79K0.0%N/A0.018%Search for SEC Filing on Google Icon
2/11/2022Bioimpact Capital LLC856,798$8.75M1.6%-0.4%2.015%Search for SEC Filing on Google Icon
2/10/2022JPMorgan Chase & Co.2,143,684$21.89M0.0%-4.3%5.041%Search for SEC Filing on Google Icon
2/10/2022Qube Research & Technologies Ltd31,447$0.32M0.0%N/A0.074%Search for SEC Filing on Google Icon
2/10/2022Rafferty Asset Management LLC346,124$3.53M0.0%+64.9%0.814%Search for SEC Filing on Google Icon
2/10/2022Citigroup Inc.267,173$2.73M0.0%+94.2%0.628%Search for SEC Filing on Google Icon
2/10/2022TD Asset Management Inc.20,418$0.21M0.0%+100.0%0.048%Search for SEC Filing on Google Icon
2/9/2022BNP Paribas Arbitrage SA39,383$0.40M0.0%+406.7%0.093%Search for SEC Filing on Google Icon
2/9/2022Dimensional Fund Advisors LP524,733$5.36M0.0%-11.0%1.234%Search for SEC Filing on Google Icon
2/8/2022Raymond James Financial Services Advisors Inc.50,242$0.51M0.0%+21.7%0.118%Search for SEC Filing on Google Icon
2/8/2022Bank of America Corp DE372,700$3.80M0.0%+36.3%0.876%Search for SEC Filing on Google Icon
2/8/2022Raymond James & Associates231,315$2.36M0.0%+71.7%0.544%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp406,967$4.16M0.0%+0.3%0.957%Search for SEC Filing on Google Icon
2/7/2022SG Americas Securities LLC46,669$0.48M0.0%-21.7%0.110%Search for SEC Filing on Google Icon
2/3/2022Cambridge Investment Research Advisors Inc.12,667$0.13M0.0%-25.1%0.030%Search for SEC Filing on Google Icon
2/2/2022New York State Common Retirement Fund22,523$0.23M0.0%-25.2%0.053%Search for SEC Filing on Google Icon
2/2/2022Fisher Asset Management LLC2,268,074$23.16M0.0%+30.5%5.334%Search for SEC Filing on Google Icon
2/1/2022Qube Research & Technologies Ltd31,447$0.32M0.0%N/A0.074%Search for SEC Filing on Google Icon
1/28/2022Allspring Global Investments Holdings LLC19,412$0.20M0.0%N/A0.046%Search for SEC Filing on Google Icon
1/26/2022Franklin Street Advisors Inc. NC23,160$0.24M0.0%+10.3%0.054%Search for SEC Filing on Google Icon
1/21/2022Golden Green Inc.41,480$0.42M0.3%-34.1%0.098%Search for SEC Filing on Google Icon
1/20/2022Nordea Investment Management AB392,110$4.12M0.0%-1.1%0.922%Search for SEC Filing on Google Icon
12/10/2021Towercrest Capital Management17,500$0.24M0.0%N/A0.041%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP338,716$4.55M0.0%-37.6%0.797%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP84,731$1.14M0.0%-86.5%0.199%Search for SEC Filing on Google Icon
11/16/2021Voloridge Investment Management LLC241,953$3.25M0.0%-30.3%0.569%Search for SEC Filing on Google Icon
11/16/2021Metropolitan Life Insurance Co NY8,442$0.11M0.0%-23.9%0.020%Search for SEC Filing on Google Icon
11/16/2021BioImpact Capital LLC860,502$11.55M1.8%+5.9%2.024%Search for SEC Filing on Google Icon
11/15/2021Point72 Hong Kong Ltd6,363$85K0.0%N/A0.015%Search for SEC Filing on Google Icon
11/15/2021Cubist Systematic Strategies LLC27,560$0.37M0.0%+409.5%0.065%Search for SEC Filing on Google Icon
11/15/2021California State Teachers Retirement System45,319$0.61M0.0%-16.2%0.107%Search for SEC Filing on Google Icon
11/15/2021Voya Investment Management LLC127,787$1.72M0.0%-7.0%0.301%Search for SEC Filing on Google Icon
11/15/2021Dimensional Fund Advisors LP589,331$7.91M0.0%-44.9%1.386%Search for SEC Filing on Google Icon
11/15/2021Franklin Resources Inc.16,556$0.22M0.0%N/A0.039%Search for SEC Filing on Google Icon
11/15/2021Lombard Odier Asset Management Switzerland SA961,139$12.90M0.8%+17.9%2.260%Search for SEC Filing on Google Icon
11/12/2021The Manufacturers Life Insurance Company21,246$0.29M0.0%-5.6%0.050%Search for SEC Filing on Google Icon
11/12/2021Credit Suisse AG27,412$0.37M0.0%+34.5%0.064%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC643,103$8.63M0.0%+5.4%1.512%Search for SEC Filing on Google Icon
11/12/2021E Fund Management Co. Ltd.11,607$0.16M0.0%N/A0.027%Search for SEC Filing on Google Icon
11/12/2021Connor Clark & Lunn Investment Management Ltd.26,211$0.35M0.0%N/A0.062%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.687,704$9.23M0.0%+55.1%1.617%Search for SEC Filing on Google Icon
11/10/2021Citigroup Inc.137,557$1.85M0.0%-26.0%0.323%Search for SEC Filing on Google Icon
11/10/2021Rafferty Asset Management LLC209,836$2.82M0.0%+73.9%0.493%Search for SEC Filing on Google Icon
11/10/2021Jupiter Asset Management Ltd.61,255$0.82M0.0%+48.4%0.144%Search for SEC Filing on Google Icon
11/9/2021Barclays PLC16,725$0.22M0.0%+17,142.3%0.039%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.3,242,085$43.51M0.0%+0.4%7.625%Search for SEC Filing on Google Icon
11/8/2021Russell Investments Group Ltd.156,507$2.10M0.0%N/A0.368%Search for SEC Filing on Google Icon
11/4/2021Abbot Financial Management Inc.10,650$0.14M0.1%N/A0.025%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG23,177$0.31M0.0%-3.0%0.055%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
G1 Therapeutics logo
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive stage small cell lung cancer. It is also developing trilaciclib, a (CDK) 4/6 inhibitor that is in Phase III clinical trials for patients with first line colorectal cancer; Phase III clinical trial for the treatment of first line triple negative breast cancer; Phase II clinical trial for patients with first line bladder cancer; Phase II clinical trial for patients with combination with the antibody-drug conjugate; and Phase II clinical trial for the treatment of neoadjuvant breast cancer. In addition, the company develops lerociclib, an oral CDK4/6 inhibitor for multiple oncology indications; and rintodestrant, an oral selective estrogen receptor degrader, which is in Phase IIa clinical trials for the treatment of estrogen receptor-positive and HER2-negative breast cancer. The company has a license agreement with EQRx, Inc. and Genor Biopharma Co. Inc. for the development and commercialization of lerociclib using an oral dosage form to treat any indication in humans, as well as Nanjing Simcere Dongyuan Pharmaceutical Co., LTD. for the development and commercialization of trilaciclib for any indication in humans through parenteral delivery, and ARC Therapeutics for the development and commercialization of a CDK2 inhibitor for all human and veterinary uses. G1 Therapeutics, Inc. was incorporated in 2008 and is headquartered in Research Triangle Park, North Carolina.
Read More on G1 Therapeutics

Today's Range

Now: $12.87
Low: $11.78
High: $12.93

50 Day Range

MA: $7.03
Low: $4.04
High: $13.01

52 Week Range

Now: $12.87
Low: $3.84
High: $16.65

Volume

872,090 shs

Average Volume

1,293,216 shs

Market Capitalization

$550.19 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.2

Who are the company insiders with the largest holdings of G1 Therapeutics?

G1 Therapeutics' top insider shareholders include:
  1. Glenn P Muir (Director)
  2. Mark A Velleca (Director)
  3. Mark A Velleca (CEO)
  4. Rajesh Malik (SVP)
  5. Terry L Murdock (COO)
  6. James S Hanson (General Counsel)
  7. John E (Jack) Jr Bailey (CEO)
  8. Rajesh Malik (Insider)
  9. Seth Rudnick (Director)
Learn More about top insider investors at G1 Therapeutics.

Who are the major institutional investors of G1 Therapeutics?

G1 Therapeutics' top institutional investors include:
  1. JPMorgan Chase & Co. — 4.98%
  2. FMR LLC — 1.14%
  3. Renaissance Technologies LLC — 1.09%
  4. Needham Investment Management LLC — 0.31%
  5. Northern Trust Corp — 0.21%
  6. Curi Wealth Management LLC — 0.20%
Learn More about top institutional investors of G1 Therapeutics stock.

Which institutional investors are selling G1 Therapeutics stock?

During the last quarter, GTHX stock was sold by these institutional investors:
  1. Northern Trust Corp
  2. Needham Investment Management LLC
  3. Group One Trading L.P.
Within the previous year, company insiders that have sold G1 Therapeutics company stock include:
  1. Glenn P Muir (Director)
  2. Mark A Velleca (Director)
  3. Mark A Velleca (CEO)
Learn More investors selling G1 Therapeutics stock.

Which institutional investors are buying G1 Therapeutics stock?

Within the previous quarter, GTHX stock was purchased by institutional investors including:
  1. Renaissance Technologies LLC
  2. Curi Wealth Management LLC
  3. Connor Clark & Lunn Investment Management Ltd.
  4. JPMorgan Chase & Co.
  5. Quantbot Technologies LP
  6. Trexquant Investment LP
  7. Ensign Peak Advisors Inc
  8. Y Intercept Hong Kong Ltd
In the previous year, these company insiders have bought G1 Therapeutics stock:
  1. Glenn P Muir (Director)
  2. Mark A Velleca (Director)
Learn More investors buying G1 Therapeutics stock.
A One Stop Shop for Everything Futures Trading
From RJO Futures   |   Ad
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.